Vanda Pharmaceuticals (VNDA) PT Raised to $24 as Jefferies Sees an Unusual Opportunity for Social Impact Investors
Tweet Send to a Friend
(Updated - February 16, 2021 7:44 AM EST)Jefferies analyst Chris Howerton raised the price target on Vanda Pharmaceuticals (NASDAQ: VNDA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
